Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice
A PRO-INFLAMMATORY ROLE FOR eNOS-DERIVED NO IN VIVO*
Linda Connelly,
Melanie Madhani, , and
Adrian J. Hobbs
Wolfson Institute for Biomedical Research, University College London, Cruciform Building, Gower Street, London WC1E 6AE, United Kingdom
Abstract:
The expression of inducible nitric-oxide synthase (iNOS) andsubsequent "high-output" nitric oxide (NO) production underliesthe systemic hypotension, inadequate tissue perfusion, and organfailure associated with septic shock. Therefore, modulatorsof iNOS expression and activity, both endogenous and exogenous,are important in determining the magnitude and time course ofthis condition. We have shown previously that NO from the constitutiveendothelial NOS (eNOS) is necessary to obtain maximal iNOS expressionand activity following exposure of murine macrophages to lipopolysaccharide(LPS). Thus, eNOS represents an important regulator of iNOSexpression in vitro. Herein, we validate this hypothesis invivo using a murine model of sepsis. A temporal reduction iniNOS expression and activity was observed in LPS-treated eNOSknock-out (KO) mice as compared with wild-type animals; thiswas reflected in a more stable hemodynamic profile in eNOS KOmice during endotoxaemia. Furthermore, in human umbilical veinendothelial cells, LPS leads to the activation of eNOS throughphosphoinositide 3-kinase- and Akt/protein kinase B-dependentenzyme phosphorylation. These data indicate that the pathogenesisof sepsis is characterized by an initial eNOS activation, withthe resultant NO acting as a co-stimulus for the expressionof iNOS, and therefore highlight a novel pro-inflammatory rolefor eNOS.
Received for publication October 22, 2004.
Revision received December 17, 2004.
* The costs of publication of this article were defrayed in partby the payment of page charges. This article must thereforebe hereby marked "advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.
This article was selected as a Paper of the Week.
Recipient of a Wellcome Trust International Prize TravellingResearch Fellowship.
Recipient of a Wellcome Trust Senior Fellowship in Basic Biomedical Sciences. To whom correspondence should be addressed. Tel.: 44-20-7679-6611; Fax: 44-20-7691-3104; E-mail: a.hobbs{at}ucl.ac.uk.
The editors suggest the following Related Resources on Science sites:
Endothelial glucocorticoid receptor is required for protection against sepsis.
J. E. Goodwin, Y. Feng, H. Velazquez, and W. C. Sessa (2013)
PNAS
110, 306-311
|Abstract »|Full Text »|PDF »
Olprinone and colforsin daropate alleviate septic lung inflammation and apoptosis through CREB-independent activation of the Akt pathway.
H. Oishi, K.-i. Takano, K. Tomita, M. Takebe, H. Yokoo, M. Yamazaki, and Y. Hattori (2012)
Am J Physiol Lung Cell Mol Physiol
303, L130-L140
|Abstract »|Full Text »|PDF »
G-protein-coupled Receptor Kinase Interactor-1 (GIT1) Is a New Endothelial Nitric-oxide Synthase (eNOS) Interactor with Functional Effects on Vascular Homeostasis.
S. Liu, R. T. Premont, and D. C. Rockey (2012)
J. Biol. Chem.
287, 12309-12320
|Abstract »|Full Text »|PDF »
Disruption of COX-2 and eNOS does not confer protection from cardiovascular failure in lipopolysaccharide-treated conscious mice and isolated vascular rings.
M. Staehr, K. Madsen, P. M. Vanhoutte, P. B. Hansen, and B. L. Jensen (2011)
Am J Physiol Regulatory Integrative Comp Physiol
301, R412-R420
|Abstract »|Full Text »|PDF »
Caveolin-1 Protects against Sepsis by Modulating Inflammatory Response, Alleviating Bacterial Burden, and Suppressing Thymocyte Apoptosis.
H. Feng, L. Guo, Z. Song, H. Gao, D. Wang, W. Fu, J. Han, Z. Li, B. Huang, and X.-A. Li (2010)
J. Biol. Chem.
285, 25154-25160
|Abstract »|Full Text »|PDF »
Simvastatin as a Treatment for Pulmonary Hypertension Trial.
M. R. Wilkins, O. Ali, W. Bradlow, J. Wharton, A. Taegtmeyer, C. J. Rhodes, H. A. Ghofrani, L. Howard, P. Nihoyannopoulos, R. H. Mohiaddin, et al. (2010) 181, 1106-1113
|Abstract »|Full Text »|PDF »
Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III.
C. C. McGown, N. J. Brown, P. G. Hellewell, C. S. Reilly, and Z. L. S. Brookes (2010)
Br. J. Anaesth.
104, 183-190
|Abstract »|Full Text »|PDF »
Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner.
A. Cauwels, E. S. Buys, R. Thoonen, L. Geary, J. Delanghe, S. Shiva, and P. Brouckaert (2009)
J. Exp. Med.
206, 2915-2924
|Abstract »|Full Text »|PDF »
sGC{alpha}1{beta}1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.
E. S. Buys, A. Cauwels, M. J. Raher, J. J. Passeri, I. Hobai, S. M. Cawley, K. M. Rauwerdink, H. Thibault, P. Y. Sips, R. Thoonen, et al. (2009)
Am J Physiol Heart Circ Physiol
297, H654-H663
|Abstract »|Full Text »|PDF »
Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction: a blood-free model in isolated mouse arteries.
N. Sennoun, C. Baron-Menguy, M. Burban, T. Lecompte, R. Andriantsitohaina, D. Henrion, A. Mercat, P. Asfar, B. Levy, and F. Meziani (2009)
Am J Physiol Heart Circ Physiol
297, H277-H282
|Abstract »|Full Text »|PDF »
Pulmonary Disease in Hamsters Infected with Leptospira interrogans: Histopathologic Findings and Cytokine mRNA Expressions.
M. Marinho, I. S. Oliveira-Junior, C. M. R. Monteiro, S. H. Perri, and R. Salomao (2009)
Am J Trop Med Hyg
80, 832-836
|Abstract »|Full Text »|PDF »
Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis.
O. Handa, J. Stephen, and G. Cepinskas (2008)
Am J Physiol Heart Circ Physiol
295, H1712-H1719
|Abstract »|Full Text »|PDF »
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension.
G.-P. Diller, S. van Eijl, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bedard, J. S. R. Gibbs, J. Bauersachs, et al. (2008)
Circulation
117, 3020-3030
|Abstract »|Full Text »|PDF »
Critical control points in the impact of the proinflammatory immune response on growth and metabolism.
T. H. Elsasser, T. J. Caperna, C-J. Li, S. Kahl, and J. L. Sartin (2008)
J Anim Sci
86, E105-E125
|Abstract »|Full Text »|PDF »
Nitric-oxide Synthase 2 Interacts with CD74 and Inhibits Its Cleavage by Caspase during Dendritic Cell Development.
D. Huang, D. T. Cai, R. Y. R. Chua, D. M. Kemeny, and S. H. Wong (2008)
J. Biol. Chem.
283, 1713-1722
|Abstract »|Full Text »|PDF »
Sepsis is associated with an upregulation of functional {beta}3 adrenoceptors in the myocardium.
S. Moniotte, C. Belge, B. Sekkali, P.B. Massion, B. Rozec, C. Dessy, and J.-L. Balligand (2007)
Eur J Heart Fail
9, 1163-1171
|Abstract »|Full Text »|PDF »
Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model.
C. van 't Veer, P. S. van den Pangaart, M. A. D. van Zoelen, M. de Kruif, R. S. Birjmohun, E. S. Stroes, A. F. de Vos, and T. van der Poll (2007)
J. Immunol.
179, 7110-7120
|Abstract »|Full Text »|PDF »
Lipopolysaccharide Induces Early Tolerance to Excitotoxicity via Nitric Oxide and cGMP.
M. Orio, A. Kunz, T. Kawano, J. Anrather, P. Zhou, and C. Iadecola (2007)
Stroke
38, 2812-2817
|Abstract »|Full Text »|PDF »
Nitrite-Derived Nitric Oxide Protects the Rat Kidney against Ischemia/Reperfusion Injury In Vivo: Role for Xanthine Oxidoreductase.
P. Tripatara, N. S.A. Patel, A. Webb, K. Rathod, F. M.J. Lecomte, E. Mazzon, S. Cuzzocrea, M. M. Yaqoob, A. Ahluwalia, and C. Thiemermann (2007)
J. Am. Soc. Nephrol.
18, 570-580
|Abstract »|Full Text »|PDF »
Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Prevents Myocardial Dysfunction in Murine Models of Septic Shock.
F. Ichinose, E. S. Buys, T. G. Neilan, E. M. Furutani, J. G. Morgan, D. S. Jassal, A. R. Graveline, R. J. Searles, C. C. Lim, M. Kaneki, et al. (2007)
Circ. Res.
100, 130-139
|Abstract »|Full Text »|PDF »
Phosphorylation of Endothelial Nitric-Oxide Synthase Is Diminished in Mesenteric Arteries from Septic Rabbits Depending on the Altered Phosphatidylinositol 3-Kinase/Akt Pathway: Reversal Effect of Fluvastatin Therapy.
N. Matsuda, Y. Hayashi, Y. Takahashi, and Y. Hattori (2006)
J. Pharmacol. Exp. Ther.
319, 1348-1354
|Abstract »|Full Text »|PDF »
Caveolin-1 Regulates NF-{kappa}B Activation and Lung Inflammatory Response to Sepsis Induced by Lipopolysaccharide.
S. Garrean, X.-P. Gao, V. Brovkovych, J. Shimizu, Y.-Y. Zhao, S. M. Vogel, and A. B. Malik (2006)
J. Immunol.
177, 4853-4860
|Abstract »|Full Text »|PDF »
Nitric Oxide Signaling via Nuclearized Endothelial Nitric-oxide Synthase Modulates Expression of the Immediate Early Genes iNOS and mPGES-1.
F. Gobeil Jr., T. Zhu, S. Brault, A. Geha, A. Vazquez-Tello, A. Fortier, D. Barbaz, D. Checchin, X. Hou, M. Nader, et al. (2006)
J. Biol. Chem.
281, 16058-16067
|Abstract »|Full Text »|PDF »
Endothelial Nitric Oxide Synthase: Host Defense Enzyme of the Endothelium?.
T. J. Rabelink and T. F. Luscher (2006)
Arterioscler Thromb Vasc Biol
26, 267-271
|Abstract »|Full Text »|PDF »